Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Diseases, Metabolic

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Diseases, Metabolic in 2 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, C1
Xue, Z1
Zhu, L1
Zhou, J1
Zhuo, L1
Zhang, J1
Zhang, X1
Liu, W1
Han, L1
Liao, W1
Beal, MF1

Reviews

1 review available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Diseases, Metabolic

ArticleYear
Metabolic disorders and neurotoxicology.
    Current opinion in neurology, 1995, Volume: 8, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Humans; Metabolic Diseases; Nerve D

1995

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Diseases, Metabolic

ArticleYear
Rhynchophylline alleviates neuroinflammation and regulates metabolic disorders in a mouse model of Parkinson's disease.
    Food & function, 2023, Apr-03, Volume: 14, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Metabolic Diseases; M

2023